HOME >> BIOLOGY >> NEWS
SEQUENOM announces publication of results from large-scale SNP study with the National Cancer Institute

San Diego, Jan. 16, 2001 SEQUENOM, Inc. (Nasdaq: SQNM) today announced the publication of the results from its large-scale SNP assay development and validation study undertaken in collaboration with the National Cancer Institute (NCI). The study, published in todays edition of the Proceedings of the National Academy of Sciences (PNAS), represents the largest SNP validation study completed to date and was accomplished in a period of less than four weeks. The results from the study were obtained using SEQUENOMs automated assay development process and proprietary MassARRAY system, which was used to analyze SNPs in pooled DNA samples. Copies of the paper are now available from the PNAS news office, 202-334-2138 or pnasnews@nas.edu.

The paper, entitled High throughput development and characterization of a genome-wide collection of gene-based SNP markers by chip-based MALDI-TOF mass spectrometry, describes work done in collaboration with the Laboratory of Population Genetics at the NCI. The study involved the development of more than 9,000 assays, which were used to confirm gene-based single nucleotide polymorphisms (SNPs) in a reference population of 94 individuals. The study succeeded in identifying 3,148 SNPs that were previously unknown.

This work has generated the largest collection of validated gene-based SNPs described to date, added Andi Braun, M.D., Ph.D., SEQUENOMs Chief Medical Officer and head of the Companys Genomics business unit. The validation of 3,646 SNPs, 86 percent of which are novel, provides a collection of assays of immediate utility to the human genetics community in the rush to improve understanding of the genetic basis of disease. SEQUENOM continues to increase its portfolio of assays, which now covers the majority of gene-based SNPs in the public domain, and has access to many proprietary SNPs through our collaborations.

The success of the study with the NCI validated two proprietary advancemen
'"/>

Contact: Tom Baker
t.baker@noonanrusso.com
415-677-4455 X 370
Noonan/Russo Communications
15-Jan-2001


Page: 1 2

Related biology news :

1. Secretary of Energy announces seven E.O. Lawrence Award Winners
2. Popular Science announces Third Annual Brilliant 10
3. The American Phytopathological Society announces 2004 awards
4. NSF announces six FIBR awards to tackle some of biologys most challenging questions
5. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
6. JGI announces community sequencing program portfolio
7. APS announces the winners of its 2004 postdoctoral fellowship in physiological genomics
8. National Corn Growers Association announces valuable maize genome data now available to scientists
9. DFG announces three percent budget increase
10. Chemical Society announces EPA awards for environmentally friendly technology
11. Nanosphere announces genetic detection advance in Nature Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... 2020 , ... BioFactura, Inc. today announced a $1 million ... & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). ... efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at ... Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... HONG KONG (PRWEB) , ... July 09, 2020 ... ... chemical compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in ... years, the PolyU research team led by Dr MA has been using the ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic impacting ... treatment. In an effort to better understand the cellular responses to COVID-19, the ... dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
Breaking Biology Technology:
Cached News: